Bath & Body Works (NYSE:BBWI) Issues Q3 Earnings Guidance

Bath & Body Works (NYSE:BBWI) updated its third quarter earnings guidance on Wednesday. The company provided EPS guidance of $0.41-0.47 for the period, compared to the consensus EPS estimate of $0.47. The company issued revenue guidance of flat to +2.5% yr/yr to ~$1.56-1.60 billion, compared to the consensus revenue estimate of $1.58 billion. Bath & Body Works also updated its FY25 guidance to $3.06-3.26 EPS.

Bath & Body Works Stock Performance

Shares of NYSE BBWI opened at $31.74 on Friday. The stock’s 50-day simple moving average is $31.96 and its 200-day simple moving average is $40.40. The firm has a market capitalization of $6.95 billion, a PE ratio of 8.18, a price-to-earnings-growth ratio of 0.96 and a beta of 1.77. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. On average, sell-side analysts forecast that Bath & Body Works will post 3.18 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 6th. Shareholders of record on Friday, August 23rd were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 2.52%. The ex-dividend date of this dividend was Friday, August 23rd. Bath & Body Works’s dividend payout ratio is currently 20.62%.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on BBWI. UBS Group cut their target price on shares of Bath & Body Works from $52.00 to $38.00 and set a neutral rating on the stock in a report on Thursday, August 29th. JPMorgan Chase & Co. dropped their price objective on shares of Bath & Body Works from $42.00 to $39.00 and set a neutral rating on the stock in a research note on Thursday, August 29th. Evercore ISI reduced their target price on shares of Bath & Body Works from $45.00 to $35.00 and set an in-line rating for the company in a report on Wednesday, August 28th. Robert W. Baird lowered their price target on Bath & Body Works from $54.00 to $45.00 and set an outperform rating on the stock in a report on Thursday, August 29th. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on Bath & Body Works from $57.00 to $54.00 and set a buy rating on the stock in a research report on Monday, August 26th. Eight investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of Moderate Buy and a consensus price target of $42.35.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.